MedPath

Clinical study for reducing the risk of progress of idiopathic osteonecrosis of the femoral head (ION) by teriparatide treatment

Not Applicable
Conditions
idiopathic osteonecrosis of the femoral head
Registration Number
JPRN-UMIN000009610
Lead Sponsor
Asahikawa Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1.Patients with contraindication of teriparatide 2.Patient who was not obtained informed consent 3.Hips already receiving osteotomy or hip arthroplasty by ION 4.Patients with severe renal dysfunction, hepatic dysfunction, and cardiac dysfunction 5.Hips with osteoarthritis changes

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath